The infection control market would grow at a CAGR of 6.68% over the predicted time frame. The market is expected to increase in value from US$ 218.7 Bn in 2022 to US$ 367 Bn in 2030.
The on infection
control Market, which provides a business strategy, research & development
activities, concise outline of the market valuation, valuable insights
pertaining to market share, size, supply chain analysis, competitive landscape
and regional proliferation of this industry.
Download
Free Sample@ https://www.precedenceresearch.com/sample/1804
Report Scope of the Infection Control Market
| Report Coverage | Details |
| Market Size by 2030 | USD 367 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 6.68% |
| Largest Market | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product & Service, End User, Geography |
A recent
report provides crucial insights along with application based and forecast
information in the Global Infection control Market. The report provides a
comprehensive analysis of key factors that are expected to drive the growth of
this market. This study also provides a detailed overview of the opportunities
along with the current trends observed in the Infection control market.
A
quantitative analysis of the industry is compiled for a period of 10 years in
order to assist players to grow in the market. Insights on specific revenue
figures generated are also given in the report, along with projected revenue at
the end of the forecast period.
Companies
and Manufacturers Covered
The study
covers key players operating in the market along with prime schemes and
strategies implemented by each player to hold high positions in the industry.
Such a tough vendor landscape provides a competitive outlook of the industry,
consequently existing as a key insight. These insights were thoroughly analysed
and prime business strategies and products that offer high revenue generation
capacities were identified. Key players of the global Infection control market
are included as given below:
Infection control Market Key Players
- Getinge AB (Sweden),
- STERIS plc.
- Advanced Sterilization Products (US),
- 3M Company (US),
- Belimed AG (Switzerland),
- Cantel Medical Corporation (US),
- MMM Group
- MATACHANA GROUP (Spain),
- Sotera Health LLC (US)
Market Segments
- Sterilization Products and Services
- Sterilization Equipment
- Heat Sterilization Equipment
- Moist Heat Sterilizers
- Dry Heat Sterilizers
- Low-Temperature Sterilization
- Hydrogen Peroxide Sterilization
- Ethylene Oxide Sterilization (ETO)
- Formaldehyde Sterilization
- Other Low-Temperature Sterilization
- Radiation Sterilization
- Filtration Sterilization
- Other Equipment
- Heat Sterilization Equipment
- Contract Sterilization Services Market
- ETO Sterilization Services
- Gamma Sterilization Services
- E-Beam Sterilization Services
- Steam Sterilization Services
- Other Sterilization Services
- Consumables and Accessories
- Sterilization Indicators
- Chemical Indicators
- Biological Indicators
- Packaging Accessories
- Sterilization Indicators
- Sterilization Equipment
- Cleaning and Disinfection Products
- Disinfectants
- Disinfectants, By Product Type
- Hand Disinfectants
- Surface Disinfectants
- Skin Disinfectants
- Instrument Disinfectants
- Disinfectants, By Formulation
- Disinfectant Wipes
- Liquid Disinfectants
- Disinfectant Sprays
- Disinfectants, By EPA Classification
- Low-Level Disinfectants
- Intermediate-Level Disinfectants
- High-Level Disinfectants
- Disinfectants, By Product Type
- Cleaning and Disinfection Equipment
- Washer-Disinfectors
- Flusher Disinfectors
- UV-Ray Disinfectors
- Ultrasonic Cleaners
- Other Cleaning and Disinfection Equipment
- Lubricants and Cleaning Solutions
- Disinfection and Cleaning Accessories
- Disinfectants
- Protective Barriers
- Medical Nonwovens
- Surgical Drapes
- Surgical Gowns
- Face Masks
- Covers and Closures
- Goggles
- Gloves
- Medical Nonwovens
- Endoscope Reprocessing Products
- Endoscope Reprocessing Consumables
- Endoscope Reprocessing Equipment
- Automated Endoscope Re-processors
- Endoscope Tracking Systems
- Other Endoscope Reprocessing Products
- Other Infection Control Products
By End User
- Hospitals & Clinics
- Medical Device Companies
- Pharmaceutical Companies
- Life Science Industry
- Food Industry
- Other
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Report Objectives
- To define, describe, and forecast the global infection
control market based on product, and region
- To provide detailed information regarding the major
factors influencing the growth of the market (drivers, opportunities, and
industry-specific challenges)
- To strategically analyze micromarkets1 with respect to
individual growth trends, future prospects, and contributions to the total
market
- To analyze opportunities in the market for stakeholders
and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to
four main regions—North America,
Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively
analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as
acquisitions, expansions, new product launches, and partnerships in the infection
control market
Table of Content
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Infection Control Market
5.1. COVID-19 Landscape: Infection Control Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Infection Control Market, By Product & Service
8.1. Infection Control Market, by Product & Service, 2022-2030
8.1.1. Sterilization Products and Services
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Cleaning and Disinfection Products
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Protective Barriers
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Endoscope Reprocessing Products
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Other Infection Control Products
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Infection Control Market, By End User
9.1. Infection Control Market, by End User, 2022-2030
9.1.1. Hospitals & Clinics
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Medical Device Companies
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Pharmaceutical Companies
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Life Science Industry
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Food Industry
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Infection Control Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.1.2. Market Revenue and Forecast, by End User (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.1.3.2. Market Revenue and Forecast, by End User (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.1.4.2. Market Revenue and Forecast, by End User (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.2.2. Market Revenue and Forecast, by End User (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.2.3.2. Market Revenue and Forecast, by End User (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.2.4.2. Market Revenue and Forecast, by End User (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.2.5.2. Market Revenue and Forecast, by End User (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.2.6.2. Market Revenue and Forecast, by End User (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.3.2. Market Revenue and Forecast, by End User (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.3.3.2. Market Revenue and Forecast, by End User (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.3.4.2. Market Revenue and Forecast, by End User (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.3.5.2. Market Revenue and Forecast, by End User (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.3.6.2. Market Revenue and Forecast, by End User (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.4.2. Market Revenue and Forecast, by End User (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.4.3.2. Market Revenue and Forecast, by End User (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.4.4.2. Market Revenue and Forecast, by End User (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.4.5.2. Market Revenue and Forecast, by End User (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.4.6.2. Market Revenue and Forecast, by End User (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.5.2. Market Revenue and Forecast, by End User (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.5.3.2. Market Revenue and Forecast, by End User (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product & Service (2017-2030)
10.5.4.2. Market Revenue and Forecast, by End User (2017-2030)
Chapter 11. Company Profiles
11.1. Getinge AB (Sweden)
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. STERIS plc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Advanced Sterilization Products (US)
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. 3M Company (US)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Belimed AG (Switzerland)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Cantel Medical Corporation (US)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. MMM Group
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. MATACHANA GROUP (Spain)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Sotera Health LLC (US)
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments